Skip to Content

Join the 'Brilinta' group to help and get support from people like you.

Brilinta News

FDA Medwatch Alert: Brilinta (ticagrelor) 90 mg tablets, 8-count Physician Sample Bottles: Recall of Lot # JB5047 - Due to Report of Another Medicine in One Bottle

Posted 27 May 2017 by Drugs.com

ISSUE: AstraZeneca is notifying physicians and consumers that it is voluntarily recalling one lot of professional (physician) sample bottles containing eight tablets of Brilinta (ticagrelor) 90mg tablets as a precautionary measure. This voluntary recall follows a report that a professional sample bottle containing eight tablets of Brilinta 90mg also contained another medicine called Zurampic ...

Statins Often Interact With Other Heart Drugs

Posted 17 Oct 2016 by Drugs.com

MONDAY, Oct. 17, 2016 – Cholesterol-lowering statins can interact with other drugs prescribed for heart disease. But there are ways to navigate the problem, according to new recommendations from the American Heart Association. Statins are among the mostly widely prescribed drugs in the United States. Roughly one-quarter of Americans age 40 and up are on a statin, according to a 2014 study by the ...

Brintellix (vortioxetine) Renamed Trintellix (vortioxetine) in U.S. to Avoid Name Confusion

Posted 4 May 2016 by Drugs.com

Deerfield, Ill., and Osaka, Japan (May 2, 2016) – Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) (collectively “Takeda”), and Lundbeck announced today that Brintellix(vortioxetine) will be marketed in the United States under the new name Trintellix(vortioxetine) starting in June of 2016. The vortioxetine product is a prescription ...

FDA Medwatch Alert: Brintellix (vortioxetine): Drug Safety Communication - Brand Name Change to Trintellix, to Avoid Confusion With Antiplatelet Drug Brilinta (ticagrelor)

Posted 4 May 2016 by Drugs.com

ISSUE:  FDA has approved a brand name change for the antidepressant Brintellix (vortioxetine) to decrease the risk of prescribing and dispensing errors resulting from name confusion with the blood-thinning medicine Brilinta (ticagrelor). The new brand name of the drug will be Trintellix, and it is expected to be available starting in June 2016. No other changes will be made to the label or ...

Side Effects Cause Some to Stop Taking Blood Thinner Brilinta

Posted 10 Nov 2015 by Drugs.com

TUESDAY, Nov. 10, 2015 – Side effects like bleeding or shortness of breath cause some heart attack survivors to stop taking a potentially lifesaving new blood thinner during clinical trials, researchers report. About one in five people assigned to take the highest dose of the blood thinner Brilinta (ticagrelor) during clinical trials stopped taking the drug due to side effects, the new research ...

FDA Approves Expanded Indication for Brilinta to Include Long-Term Use in Patients with a History of Heart Attack

Posted 8 Sep 2015 by Drugs.com

Thursday, 3 September 2015 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Brilinta (ticagrelor) tablets at a new 60mg dose to be used in patients with a history of heart attack beyond the first year. With this expanded indication, Brilinta is now approved to reduce the rate of cardiovascular death, myocardial infarction (MI, also known as heart attack) ...

FDA Medwatch Alert: Brintellix (vortioxetine) and Brilinta (ticagrelor): Drug Safety Communication - Name Confusion

Posted 2 Aug 2015 by Drugs.com

ISSUE: FDA is warning health care professionals and patients that reports of confusion between the antidepressant Brintellix and anti-blood clotting medication Brilinta have resulted in the wrong medication being prescribed or dispensed. FDA determined that the main reason for the confusion between these two medications is the similarity of their brand (proprietary) names. None of the reports ...

Wide Variations Seen in U.S. Stroke Care

Posted 7 Jul 2015 by Drugs.com

TUESDAY, July 7, 2015 – Americans' odds of receiving a drug that can halt strokes in progress may vary widely depending on their ZIP codes, a new study finds. Experts said the findings, reported in the July issue of the journal Stroke, help verify what everyone has suspected: There are disparities in emergency stroke care across the United States, specifically in the use of a clot-busting drug ...

FDA Approves New Crushing Option for the Administration of Brilinta

Posted 30 Mar 2015 by Drugs.com

March 30, 2015 – AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow Brilinta 90 mg tablets whole. Unlike other P2Y12 inhibitors, Brilinta has FDA approval to be crushed and administered in water by swallowing or via nasogastric tube. “We know that s ...

Newer Blood Thinner May Improve Outcomes for Heart Attack Survivors

Posted 15 Mar 2015 by Drugs.com

SATURDAY, March 14, 2015 – Long-term use of the newer anti-clotting drug Brilinta cut heart attack survivors' future risk of heart attack, stroke or heart-related death, a new study found. The study was funded by Brilinta's maker, AstraZeneca, and was scheduled for presentation Saturday in San Diego at the annual meeting of the American College of Cardiology (ACC). One expert not connected to ...

Guidelines Issued for New Blood Thinner Brilinta

Posted 16 Jul 2012 by Drugs.com

MONDAY, July 16 – The new blood-thinning drug Brilinta should be considered along with older drugs to treat patients with unstable angina, according to updated guidelines. Unstable angina occurs when a partially blocked coronary artery deprives the heart of blood and oxygen. The updated guidelines were issued jointly by the American Heart Association Task Force on Practice Guidelines and the ...

Rx for Heart Patients: Healthier Living, Medication

Posted 3 Nov 2011 by Drugs.com

THURSDAY, Nov. 3 – A healthy lifestyle and appropriate medications can help people with heart disease live longer and avoid a heart attack or stroke, according to new guidelines from the American College of Cardiology Foundation and the American Heart Association. Following the updated recommendations can also improve quality of life, reduce the need for surgical procedures to open blocked ...

Ask a Question

Further Information

Related Condition Support Groups

Acute Coronary Syndrome, Prevention of Atherothrombotic Events

Brilinta Patient Information at Drugs.com